Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joep M A Lange

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Plos Medicine|July 13, 2005
We must not let protestors derail trials of pre-exposure prophylaxis for HIVJoep M A Lange
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
Efficacy and durability of nevirapine in antiretroviral drug näive patientsJoep M A Lange
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
Editorial commentary: Under the spell of the red queenJoep M A Lange
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
"Test and treat": is it enough?Joep M A Lange
IAPAC Monthly|April 26, 2003
Time to move on HIV/AIDS treatment and careBernhard Schwartländer, Joep M A Lange
Antiviral Therapy|October 14, 2014
The discovery and development of antiretroviral agentsJoep M A Lange, Jintanat Ananworanich
Science (New York, N.Y.)|June 26, 2004
Access for all?Joep M A Lange, Vallop Thaineua
Current Opinion in HIV and AIDS|December 4, 2012
Introduction 15 million on ART by 2015: a realistic target or just a dreamJoep M A Lange, Bernhard Schwartländer
Lancet (London, England)|July 6, 2004
Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV preventionHelene Gayle, Joep M A Lange
The Lancet. Infectious Diseases|June 29, 2004
Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and developmentDavid A Cooper, Joep M A Lange
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Plos Medicine|July 13, 2005
We must not let protestors derail trials of pre-exposure prophylaxis for HIVJoep M A Lange
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
Efficacy and durability of nevirapine in antiretroviral drug näive patientsJoep M A Lange
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
Editorial commentary: Under the spell of the red queenJoep M A Lange
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
"Test and treat": is it enough?Joep M A Lange
IAPAC Monthly|April 26, 2003
Time to move on HIV/AIDS treatment and careBernhard Schwartländer, Joep M A Lange
Antiviral Therapy|October 14, 2014
The discovery and development of antiretroviral agentsJoep M A Lange, Jintanat Ananworanich
Science (New York, N.Y.)|June 26, 2004
Access for all?Joep M A Lange, Vallop Thaineua
Current Opinion in HIV and AIDS|December 4, 2012
Introduction 15 million on ART by 2015: a realistic target or just a dreamJoep M A Lange, Bernhard Schwartländer
Lancet (London, England)|July 6, 2004
Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV preventionHelene Gayle, Joep M A Lange
The Lancet. Infectious Diseases|June 29, 2004
Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and developmentDavid A Cooper, Joep M A Lange
Pageof 11